Qube Research & Technologies (QRT)
NUVB icon

Qube Research & Technologies (QRT)’s Nuvation Bio NUVB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.76M Buy
2,042,312
+761,413
+59% +$4.24M 0.01% 1361
2025
Q4 		$11.5M Buy
+1,280,899
New +$7.93M 0.01% 1259
2024
Q4 		– Sell
-163,450
Closed -$374K – 3719
2024
Q3 		$374K Sell
163,450
-33,567
-17% -$102K ﹤0.01% 2359
2024
Q2 		$575K Buy
+197,017
New +$601K ﹤0.01% 2099
2023
Q4 		– Sell
-11,313
Closed -$15.2K – 4618
2023
Q3 		$15.2K Buy
+11,313
New +$18.8K ﹤0.01% 3222

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NUVB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Nuvation Bio (NUVB) stake by 59% in Q1 2026, buying an estimated $4.24M and bringing the position to 2,042,312 shares worth $8.76M. The position accounts for 0.01% of the portfolio, ranked #1361.

Qube Research & Technologies (QRT) first reported a position in NUVB in Q3 2023 and has held it in 5 quarters since. The position peaked at $11.5M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,042,312 shares of Nuvation Bio worth $8.76M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 761,413 Nuvation Bio shares in Q1 2026, an estimated $4.24M.
  • Nuvation Bio made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1361 holding.
  • Qube Research & Technologies (QRT) first reported a position in Nuvation Bio in Q3 2023 and has held it in 5 quarters since.
  • Qube Research & Technologies (QRT)'s Nuvation Bio position peaked at $11.5M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.